— Latest update: July 2022 —
Quasi-drugs are medicines for the purpose of prevention of symptoms and hygiene: they have a weaker effect on the human body than medicines. Some products, such as nutritional drinks, shampoos, and hair-growth products, are considered “quasi-drugs”, whereas skincare products that are less effective than “quasi-drugs” are classified as cosmetics.
This different category of products, which doesn't have an EU counterpart, imply vastly different standards and regulations than other pharmaceutical products. Pre-marketing approvals, registration of ingredients and means of manufacturing are highly regulated for these over-the counter products. Thus, EU companies need to consider a variety of new aspects for their implementation on the Japanese market.
> For more information on Cosmetics, please visit our specific sectorial page
What are the business opportunities in Japan’s public healthcare and what you need to do to become a supplier?While a large portion of Japan’s healthcare system is privately managed, about 30% of
This website and related activities are managed by the EU-Japan Centre for Industrial Cooperation, a joint venture between the European Commission's Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) and the Japanese Government's Ministry of Economy, Trade & Industry (METI).
Hundreds of web pages with up-to-date information on Japan, more than 400 market reports and recorded webinars available as well as a lot of detailed information on Japanese business culture.